表紙
市場調查報告書

穿戴式注射器的全球市場:2020年∼2024年

Wearable Injectors Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 917060
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
穿戴式注射器的全球市場:2020年∼2024年 Wearable Injectors Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月08日內容資訊: 英文 144 Pages
簡介

全球穿戴式注射器市場上,慢性疾病的盛行率增加,新產品的銷售數增加,自我給藥型藥物輸送設備的需求增加等成為成長促進因素,在預測期間內預計將以約11%的年複合成長率擴大。但,藥物輸送的替代方案的存在,穿戴式注射器相關的高成本,穿戴式注射器相關的網路安全的疑慮等要素,可能妨礙在預測期間內穿戴式注射器產業的成長。

本報告提供全球穿戴式注射器市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:場規模及預測(2019年∼2024年)
  • 開身體型
  • 關斷身體型
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 穿戴式注射器的技術進步
  • 聯盟與合作的增加
  • 生技藥品的開發強化

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Amgen Inc.
  • Becton, Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Ypsomed AG

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40104

About this market

Technavio's wearable injectors market analysis considers sales from on-body wearable injectors and off-body wearable injectors products. Our study also finds the sales of wearable injectors in Asia, Europe, North America, and ROW. In 2019, the on-body wearable injectors segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the convenience of self-administration of drugs and increasing prevalence of cancer, diabetes, and other chronic diseases will play a significant role in the on-body wearable injectors segment to maintain its market position. Also, our global wearable injectors market report looks at factors such as increasing prevalence of chronic diseases, increasing number of new product launches, and increasing demand for self-administrative drug delivery devices. However, presence of alternative methods for drug delivery, high costs associated with wearable injectors, and cybersecurity concerns related to wearable injectors may hamper the growth of the wearable injectors industry over the forecast period.

Overview

Increasing demand for self-administrative drug delivery devices

Specific drug delivery systems have recently become available for patients, which facilitate self-administration and thus, ensure patient's adherence to medication. Self-administration of drugs improves health outcomes and reduces the admission rate at hospitals and clinics for regular treatment. A wearable injector is a specific type of self-injector drug delivery device that is widely accepted by healthcare professionals and patients worldwide. Thus, the increasing demand for self-administrative drug delivery devices will lead to the expansion of the global wearable injectors market at a CAGR of almost 11% during the forecast period.

Technological advancements in wearable injectors

Wearable injectors are preferred self-injection devices, which are primarily used in healthcare settings for the treatment of patients with diabetes, cancer, arthritis, and autoimmune diseases. They are widely accepted by patients with diabetes and pain due to various medical reasons. These advanced injectable devices facilitate accurate and automatic delivery of drugs in high volume and with high viscosity. Most pharmaceutical and medical device companies are focusing on new technologies that can enhance the effectiveness and accuracy of the medication by minimizing the frequency of injections for drug delivery with regular injectors and syringes. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global wearable injectors market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global wearable injectors market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading wearable injectors manufacturers, that include Amgen Inc., Becton, Dickinson, and Co., Enable Injections Inc., Gerresheimer AG, Insulet Corp., Medtronic Plc, Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., and Ypsomed AG.

Also, the wearable injectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • On-body wearable injectors - Market size and forecast 2019-2024
  • Off-body wearable injectors - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advancements in wearable injectors
  • Increasing number of partnerships and collaborations
  • Increasing focus on development of biologics

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amgen Inc.
  • Becton, Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Ypsomed AG

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: On-body wearable injectors - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: On-body wearable injectors - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Off-body wearable injectors - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Off-body wearable injectors - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Product launch details and market impact analysis
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Amgen Inc. - Vendor overview
  • Exhibit 46: Amgen Inc. - Business segments
  • Exhibit 47: Amgen Inc. - Organizational developments
  • Exhibit 48: Amgen Inc. - Geographic focus
  • Exhibit 49: Amgen Inc. - Key offerings
  • Exhibit 50: Amgen Inc. - Key customers
  • Exhibit 51: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 52: Becton, Dickinson and Co. - Product segments
  • Exhibit 53: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 54: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 55: Becton, Dickinson and Co. - Segment focus
  • Exhibit 56: Becton, Dickinson and Co. - Key offerings
  • Exhibit 57: Becton, Dickinson and Co. - Key customers
  • Exhibit 58: Enable Injections Inc. - Vendor overview
  • Exhibit 59: Enable Injections Inc. - Product segments
  • Exhibit 60: Enable Injections Inc. - Organizational developments
  • Exhibit 61: Enable Injections Inc. - Key offerings
  • Exhibit 62: Enable Injections Inc. - Key customers
  • Exhibit 63: Gerresheimer AG - Vendor overview
  • Exhibit 64: Gerresheimer AG - Business segments
  • Exhibit 65: Gerresheimer AG - Organizational developments
  • Exhibit 66: Gerresheimer AG - Geographic focus
  • Exhibit 67: Gerresheimer AG - Segment focus
  • Exhibit 68: Gerresheimer AG - Key offerings
  • Exhibit 69: Gerresheimer AG - Key customers
  • Exhibit 70: Insulet Corp. - Vendor overview
  • Exhibit 71: Insulet Corp. - Business segments
  • Exhibit 72: Insulet Corp. - Organizational developments
  • Exhibit 73: Insulet Corp. - Geographic focus
  • Exhibit 74: Insulet Corp. - Key offerings
  • Exhibit 75: Insulet Corp. - Key customers
  • Exhibit 76: Medtronic Plc - Vendor overview
  • Exhibit 77: Medtronic Plc - Business segments
  • Exhibit 78: Medtronic Plc - Organizational developments
  • Exhibit 79: Medtronic Plc - Segment focus
  • Exhibit 80: Medtronic Plc - Key offerings
  • Exhibit 81: Medtronic Plc - Key customers
  • Exhibit 82: Tandem Diabetes Care Inc. - Vendor overview
  • Exhibit 83: Tandem Diabetes Care Inc. - Business segments
  • Exhibit 84: Tandem Diabetes Care Inc. - Organizational developments
  • Exhibit 85: Tandem Diabetes Care Inc. - Key offerings
  • Exhibit 86: Tandem Diabetes Care Inc. - Key customers
  • Exhibit 87: Valeritas Inc. - Vendor overview
  • Exhibit 88: Valeritas Inc. - Business segments
  • Exhibit 89: Valeritas Inc. - Organizational developments
  • Exhibit 90: Valeritas Inc. - Key offerings
  • Exhibit 91: Valeritas Inc. - Key customers
  • Exhibit 92: West Pharmaceutical Services Inc. - Vendor overview
  • Exhibit 93: West Pharmaceutical Services Inc. - Business segments
  • Exhibit 94: West Pharmaceutical Services Inc. - Organizational developments
  • Exhibit 95: West Pharmaceutical Services Inc. - Geographic focus
  • Exhibit 96: West Pharmaceutical Services Inc. - Segment focus
  • Exhibit 97: West Pharmaceutical Services Inc. - Key offerings
  • Exhibit 98: West Pharmaceutical Services Inc. - Key customers
  • Exhibit 99: Ypsomed AG - Vendor overview
  • Exhibit 100: Ypsomed AG - Business segments
  • Exhibit 101: Ypsomed AG - Organizational developments
  • Exhibit 102: Ypsomed AG - Geographic focus
  • Exhibit 103: Ypsomed AG - Segment focus
  • Exhibit 104: Ypsomed AG - Key offerings
  • Exhibit 105: Ypsomed AG - Key customers
  • Exhibit 106: Validation techniques employed for market sizing
  • Exhibit 107: Definition of market positioning of vendors
Back to Top